Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 43Breast Neoplasms 31Prostatic Neoplasms 27Colorectal Neoplasms 26Lung Neoplasms 17Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 11Hematologic Neoplasms 11Uterine Cervical Neoplasms 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3

Interventions

Venlafaxine Hydrochloride 1Specimen Handling 1Psilocybin 1Interviews as Topic 1Dignity Therapy 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Depressive Disorder × Interviews as Topic × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡